LDK which bottom around 6 dollar now is over 7.30 dollar.
Dendreon pharma is doing pretty well and reached its upper limit 40 now. It will be interesting to see what happens tomorrow.
If overall market supports DNDN has potential to go further up as its Q came pretty well (doubling revenue). DNDN also has possibility to be acquired by a bigger company, such as Roche.
Roche was took over Genentech when I was a shareholder of DNA.
Then DNA's executives came on board of DNDN.
